Funding for this research was provided by:
Patronage division of Angers University Hospital (2020-001602-34)
Received: 15 May 2020
Accepted: 23 November 2020
First Online: 28 December 2020
Ethics approval and consent to participate
: The protocol received approval from the French “Sud-Est V Ethics Committee” (20.04.03.65603, Grenoble, France; ref., 20-ANGE-01) and was also approved by the French National Agency for Medicines and Health Products Safety (ANSM). Three successive amendments to the protocol were submitted on 21 April 2020, 15 May 2020, and 17 July 2020, all of which were approved by regulatory authorities. Written, informed consent to participate will be obtained from all participants (or written informed consent form obtained from the trusted person, or emergency inclusion procedure in the context of lockdown, as appropriate).
: Not applicable
: CA occasionally serves as a consultant for Mylan Laboratories Inc (2020). All authors declare they do not have any other financial and personal conflicts of interest with this manuscript.